Skip to main content
13 December 2019
Last updated:
Friday 13 December 2019

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
    • News
    • Appointments
    • Events
  • About MedNous
  • Research Directory
  • Contact Us

News

Shire acquires rights to experimental anti-scarring treatment

Thursday 21 June 2007

Shire Plc has agreed to pay up to $825 million for an experimental drug for the prevention and reduction of scarring in connection with surgery. The licensing agreement, with Renovo Group Plc, would give Shire exclusive rights to market the drug, called Juvista, in every country except the member states of the European Union.

Read more

Charities can fund businesses, says Wellcome Trust officer

Wednesday 20 June 2007

There are a growing number of instances where charitable organisations can provide money to profit-making companies and still demonstrate that they are working in the public interest, according Richard Seabrook, head of business development at the Wellcome Trust.

Read more

AMT's IPO sells well

Wednesday 20 June 2007

Amsterdam Molecular Therapeutics AMT Holding NV, which develops gene-based therapies for orphan diseases, raised €50 million in an initial public offering on the Euronext Amsterdam stock exchange.

Read more

Swedish biotech pipeline getting bigger

Tuesday 19 June 2007

Swedish biotech companies increased their pipeline of drug candidates substantially in 2007 compared with a year earlier, according to a survey conducted by SwedenBio, an industry association, and two government agencies, Invest in Sweden Agency (ISA) and Vinnova.

News Link
Swedish Pipeline Report
Read more

EMEA guideline on first-in-man trials due out in July

Friday 15 June 2007

A guideline outlining how companies should prepare to conduct first-in-man studies of novel medicinal products in Europe, should be completed in July, 2007, according to Patrick Le Courtois, head of the Unit for Pre-Authorisation of Medicines for Human Use at the European Medicines Agency (EMEA).

Read more

Amsterdam Molecular Therapeutics announces IPO

Thursday 14 June 2007

Amsterdam Molecular Therapeutics (AMT) Holding NV, which develops gene-based therapies for orphan diseases, expects to raise around €45 million in an initial public offering on the Eurolist-by-Euronext section of the Euronext Amsterdam Stock Exchange.

News Link
Amsterdam Molecular Therapeutics
Read more

Santaris presents data on new RNA antagonist

Wednesday 13 June 2007

Santaris Pharma A/S of Denmark announced at the June 2007 annual meeting of the American Society of Clinical Oncology in Chicago that its RNA antagonist for chronic lymphocytic leukaemia (CLL) showed promising results in an initial Phase I/II clinical trial.

News Link
Santaris A/S
Read more

International biotech patent filings drop by two thirds over four years

Wednesday 13 June 2007

The number of international patent applications filed by biotechnology companies under the Patent Cooperation Treaty (PCT) dropped by two-thirds from 2002 to 2006, while applications to national and regional agencies were little changed over the same period, according to the UK solicitors, Marks & Clerk.

News Link
Marks & Clerk
Read more

Biotech CEOs take AIM and smile

Tuesday 12 June 2007

Light regulation, low cost and flexible admission criteria make the London Stock Exchange’s Alternative Investment Market (AIM) an attractive venue for small companies that want to issue shares for the first time, according to the chief executive officers of four life science companies that have issued IPOs on AIM since 2004.

Read more

European biotech revenues up 13% in 2006

Sunday 3 June 2007

The European biotechnology industry increased its revenues by 13% in 2006, while narrowing its losses. At the same time, spending on research and development increased, especially on the part of the 32 companies that made initial public offerings during the year.

Read more

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 468
  • Page 469
  • Page 470
  • Page 471
  • Page 472
  • Page 473
  • Page 474
  • Current page 475
  • Page 476
  • Next page next ›
  • Last page last »

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Jacques Biton joins supervisory board at Nosopharm
Sunday December 8 2019
Norman Baylor joins science board at Valneva
Sunday December 8 2019
Vectura appoints Will Downie as CEO
Sunday December 8 2019
Santhera appoints Dario Eklund as CEO
Sunday December 8 2019
Robin Bhattacherjee is new CEO at Actimed
Sunday December 8 2019

© 2019 Evernow Publishing Ltd. Powered by Drupal.